Lee M Graves Selected Research

Lee M Graves Research Topics

Disease

32	Neoplasms (Cancer) 10/2023 - 07/2002
6	Triple Negative Breast Neoplasms 01/2023 - 04/2012
6	Leukemia 10/2022 - 10/2004
5	Breast Neoplasms (Breast Cancer) 10/2022 - 09/2011
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 09/2010
4	Infections 10/2023 - 03/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2018
3	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2011
3	Adenocarcinoma 11/2021 - 01/2017
2	Inflammation (Inflammations) 10/2023 - 02/2007
2	Carcinogenesis 01/2023 - 06/2008
2	Starvation 10/2011 - 09/2002
2	Myeloid Leukemia (Leukemia, Myelocytic) 11/2010 - 09/2002
2	T-Cell Leukemia (Leukemia, T Cell) 01/2009 - 08/2008
2	Acute Erythroblastic Leukemia (Erythroleukemia) 09/2002 - 08/2002
1	Coronavirus Infections 10/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	Fibrosis (Cirrhosis) 10/2023
1	Spastic ataxia Charlevoix-Saguenay type 11/2022
1	Cerebellar Ataxia (Dysmetria) 11/2022
1	Ataxia (Dyssynergia) 11/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Obesity 01/2018
1	Glioma (Gliomas) 12/2017
1	Glioblastoma (Glioblastoma Multiforme) 10/2017
1	Melanoma (Melanoma, Malignant) 05/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2013
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Tics (Tic) 09/2011
1	Cysts 07/2011
1	Ovarian Neoplasms (Ovarian Cancer) 07/2011
1	Carcinoma (Carcinomatosis) 07/2011
1	Ovarian Cysts (Ovarian Cyst) 07/2011
1	Reperfusion Injury 11/2010

Drug/Important Bio-Agent (IBA)

17	Phosphotransferases (Kinase)IBA 10/2023 - 11/2010
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2003
6	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 06/2008
5	Protein Kinases (Protein Kinase)IBA 12/2020 - 09/2010
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 07/2002
4	TIC10 compoundIBA 01/2023 - 01/2019
4	NucleosidesIBA 01/2011 - 08/2002
3	Transcription Factors (Transcription Factor)IBA 12/2017 - 09/2011
3	Tyrosine (L-Tyrosine)FDA Link 12/2017 - 01/2013
2	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2017
2	Gemcitabine FDA Link 01/2023 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 10/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 07/2002
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 05/2014
2	ClaudinsIBA 03/2018 - 09/2011
2	trametinibIBA 01/2017 - 05/2014
2	bcr-abl Fusion ProteinsIBA 01/2013 - 06/2008
2	Glucose (Dextrose)FDA LinkGeneric 10/2011 - 12/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2009 - 08/2002
2	pyrimidineIBA 03/2006 - 09/2002
1	MTOR InhibitorsIBA 10/2023
1	Viral ProteinsIBA 10/2023
1	RNA (Ribonucleic Acid)IBA 06/2023
1	Mitochondrial DNA (mtDNA)IBA 05/2023
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 05/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Growth InhibitorsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	IntegrinsIBA 11/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	TubulinIBA 01/2021
1	CalpainIBA 01/2021
1	Tubulin ModulatorsIBA 01/2021
1	OTS167IBA 12/2020
1	1- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA 12/2020
1	JNK-IN-8IBA 01/2020
1	Gentian Violet (Violet, Crystal)FDA Link 01/2020
1	resazurinIBA 01/2020
1	Amino Acids FDA Link 07/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	EnzymesIBA 07/2019
1	Sepharose (Agarose)IBA 03/2018
1	Phenobarbital (Luminal)FDA Link 03/2018
1	LipidsIBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	VaccinesIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	EphA2 ReceptorIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Lapatinib (GW572016)FDA Link 04/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2014
1	VemurafenibIBA 05/2014
1	dabrafenibIBA 05/2014
1	SNX-7081IBA 04/2013
1	src-Family KinasesIBA 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 07/2011
1	rho Guanine Nucleotide Dissociation Inhibitor alphaIBA 07/2011
1	matrigelIBA 07/2011
1	Glucagon (Glukagon)FDA Link 11/2010

Therapy/Procedure

12	Therapeutics 10/2023 - 04/2012
5	Drug Therapy (Chemotherapy) 10/2022 - 07/2002
1	Oral Administration 01/2022
1	Aftercare (After-Treatment) 01/2019